Cis‐platinum vestibular toxicity

S. D. Schaefer, C. G. Wright, J. D. Post, E. P. Frenkel

Research output: Contribution to journalArticle

57 Scopus citations

Abstract

Cis‐diamminedichloroplatinum has been proven to be an effective neoplastic agent. Nephrotoxicity and ototoxicity are two prominent side effects of this drug. Investigation of ototoxicity has been limited to auditory function. This report details the first known case of vestibular toxicity following platinum therapy. In addition, a prospective vestibular testing program is reported. Cancer 47:857–8589, 1981.

Original languageEnglish (US)
Pages (from-to)857-859
Number of pages3
JournalCancer
Volume47
Issue number5
DOIs
StatePublished - Mar 1 1981

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Cis‐platinum vestibular toxicity'. Together they form a unique fingerprint.

  • Cite this

    Schaefer, S. D., Wright, C. G., Post, J. D., & Frenkel, E. P. (1981). Cis‐platinum vestibular toxicity. Cancer, 47(5), 857-859. https://doi.org/10.1002/1097-0142(19810301)47:5<857::AID-CNCR2820470508>3.0.CO;2-M